Table 1 Sociodemographic, clinical, and laboratory characteristics for the population in Model 1

Sex (%F)

59.70%

52.07%

51.12%

42.86%

Stratum

Low (1–2) %

4.42%

4.40%

4.47%

1.78%

Mid-level (3–4) %

90.61%

89.38%

88.44%

94.65%

High (5–6) %

4.97%

6.22%

7.09%

3.57%

Region

Bogotá %

63.64%

65.54%

65.29%

71.44%

Eastern %

5.52%

6.99%

6.71%

10.71%

Central %

13.17%

8.55%

6.35%

7.14%

Pacific %

11.36%

12.44%

15.30%

3.57%

Caribbean %

6.23%

6.48%

6.35%

7.14%

Other

0.08%

0%

0%

0%

Marital Status

Married %

45.35%

43.26%

41.42%

53.57%

Unmarried %

54.65%

56.74%

58.58%

46.43%

Age (IQR)

77 (72–81)

77 (71–81)

76 (71–80)

66 (57–73)

Lab tests (IQR)

eGFR mL/min/1.73 m2

48.78 (40.18–55.20)

47.11 (37.22–53.02)

43.34 (32.44–53.01)

22.62 (15.53–30.33)

Triglycerides mg/dL

133.95 (102–180.12)

138.2 (104–192.72)

134.1 (105–191.42)

162.1 (112.57–239.32)

Hemoglobin gr/dL

14 [13,14,15]

14.1 (12.8–15.1)

13.9 (12.5–15.1)

12.35 (11.07–14.5)

Creatinine mg/dL

1.24 (1.05–1.47)

1.32 (1.11–1.54)

1.36 (1.16–1.84)

2.58 (1.99–3.22)

Potassium mg/dL

4.52 (4.23–4.88)

4.58 (4.24–4.96)

4.61 (4.22–5.01)

4.93 (4.42–5.35)

Cholesterol HDL mg/dL

49.95 (40.79–60.1)

48.3 (39.4–59.3)

47.65 (38.87–56.8)

43.75 (36.41–52.57)

Cholesterol LDL mg/dL

102.21 (79.19–127.53)

102.68 (77.04–126.05)

97.58 (73.75–124.07)

99.28 (75.49–132.49)

Comorbidities

Diabetes

24.68%

31.60%

36.19%

44.64%

Hypertension

92.90%

88.08%

87.31%

75%

Anemia

3.85%

4.40%

5.22%

3.57%

Coronary disease.

18.14%

20.72%

22.39%

16.07%

Cerebrovascular disease

1.42%

-

-

0%

Heart failure

15.06%

17.87

20.15%

12.5%

Rheumatoid arthritis

1.49%

-

-

-

Consumption of NSAIDs

28.08%

23.83%

20.52%

17.85%